Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · IEX Real-Time Price · USD
2.615
-0.005 (-0.19%)
Mar 28, 2024, 12:54 PM EDT - Market open
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $484.84 million as of March 28, 2024. Its market cap has increased by 311.23% in one year.
Market Cap
484.84M
Enterprise Value
943.54M
1-Year Change
311.23%
Ranking
Category
Stock Price
$2.64
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $484.84M, an increase of 137.55%. That is a compound annual growth rate of 8.38%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 26, 2024 | 499.60M | 3.05% |
Mar 25, 2024 | 484.80M | 14.39% |
Mar 22, 2024 | 423.80M | 8.53% |
Mar 21, 2024 | 390.50M | -3.65% |
Mar 20, 2024 | 405.30M | 5.30% |
Mar 19, 2024 | 384.90M | 1.45% |
Mar 18, 2024 | 379.40M | -0.97% |
Mar 15, 2024 | 383.10M | 0.98% |
Mar 14, 2024 | 379.40M | -6.39% |
Mar 13, 2024 | 405.30M | 6.83% |
Mar 12, 2024 | 379.40M | -3.29% |
Mar 11, 2024 | 392.30M | -3.21% |
Mar 8, 2024 | 405.30M | -3.93% |
Mar 7, 2024 | 421.90M | -7.32% |
Mar 6, 2024 | 455.20M | 2.50% |
Mar 5, 2024 | 444.10M | -1.64% |
Mar 4, 2024 | 451.50M | -4.32% |
Mar 1, 2024 | 471.90M | 1.59% |
Feb 29, 2024 | 464.50M | -2.33% |
Feb 28, 2024 | 475.60M | -11.38% |
Feb 27, 2024 | 536.70M | 79.44% |
Feb 26, 2024 | 299.10M | 0.77% |
Feb 23, 2024 | 296.80M | -0.77% |
Feb 22, 2024 | 299.10M | 0.77% |
Feb 21, 2024 | 296.80M | -2.62% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PetIQ | 513.28M |
UroGen Pharma | 510.47M |
Orthofix Medical | 509.48M |
IGM Biosciences | 508.50M |
Replimune Group | 506.45M |
Marinus Pharmaceuticals | 492.06M |
Revance Therapeutics | 489.82M |
Lexicon Pharmaceuticals | 487.55M |